KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Cash & Current Investments (2016 - 2025)

Fulgent Genetics' Cash & Current Investments history spans 10 years, with the latest figure at $336.1 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 30.21% year-over-year to $336.1 million; the TTM value through Dec 2025 reached $336.1 million, up 30.21%, while the annual FY2025 figure was $336.1 million, 30.21% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $336.1 million at Fulgent Genetics, down from $375.8 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $585.1 million in Q1 2022 and bottomed at $213.1 million in Q3 2024.
  • The 5-year median for Cash & Current Investments is $369.2 million (2021), against an average of $386.6 million.
  • The largest annual shift saw Cash & Current Investments soared 1451.51% in 2021 before it crashed 54.45% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $362.7 million in 2021, then soared by 45.1% to $526.2 million in 2022, then fell by 19.4% to $424.2 million in 2023, then tumbled by 39.15% to $258.1 million in 2024, then soared by 30.21% to $336.1 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Cash & Current Investments are $336.1 million (Q4 2025), $375.8 million (Q3 2025), and $292.9 million (Q2 2025).